<?xml version="1.0" encoding="UTF-8"?>
<ref id="B75-vaccines-08-00273">
 <label>75.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Nasar</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Matassov</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Seymour</surname>
    <given-names>R.L.</given-names>
   </name>
   <name>
    <surname>Latham</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Gorchakov</surname>
    <given-names>R.V.</given-names>
   </name>
   <name>
    <surname>Nowak</surname>
    <given-names>R.M.</given-names>
   </name>
   <name>
    <surname>Leal</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Hamm</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Eldridge</surname>
    <given-names>J.H.</given-names>
   </name>
   <name>
    <surname>Tesh</surname>
    <given-names>R.B.</given-names>
   </name>
  </person-group>
  <article-title>Recombinant Isfahan virus and vesicular stomatitis virus vaccine vectors provide durable, multivalent, single dose protection against lethal Alphavirus challenge</article-title>
  <source>J. Virol.</source>
  <year>2017</year>
  <volume>91</volume>
  <fpage>e01729-16</fpage>
  <pub-id pub-id-type="doi">10.1128/JVI.01729-16</pub-id>
  <?supplied-pmid 28148802?>
  <pub-id pub-id-type="pmid">28148802</pub-id>
 </element-citation>
</ref>
